Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
Xylazine is a veterinary tranquilizer primarily used in animals, but it has increasingly been found as an adulterant in illicit opioid supplies, particularly in North America. It is not approved for human use and poses significant health risks when misused, contributing to overdose deaths. Structurally, xylazine is a non-opioid sedative analgesic, and its mechanism involves acting on alpha-2 adrenergic receptors, leading to sedation and muscle relaxation. The drug's presence in the street drug supply has raised public health concerns due to its potential to exacerbate the opioid crisis. Researchers are actively studying its impact and seeking strategies to mitigate its harmful effects on population health.
仅用于科研。不用于诊断过程。未经明确授权不得转售。